maintaining weight loss after glp-1 Treatment Researchers and the public alike

[DOI] [PubMed] [Google Scholar] 45.Williamson A., Hoggart B

A July 2024 study found that people who were taking semaglutide were about 4 times more likely to develop NAION compared to the control group

High-Risk Drug Classes and Interaction Concerns Not all medications are equally affected when used alongside GLP-1 therapies

Requires Long-Term Use to Maintain Results Speaking of results, heres one of the biggest downsides

Semaglutide and tirzepatide, two FDA-approved GLP-1 medications, help regulate blood sugar while reducing hunger

1 Studies have also shown significant long-term weight loss in patients using GLP-1 analogs